RTOG-P-0011
|
RTOG
|
Phase III Randomized Study of Adjuvant Therapy For High Risk PT2-3N0 Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-P-0014
|
RTOG
|
A Phase III Randomized Study of Patients With High Risk; Hormone-Naive Prostate Cancer: Androgen Blockade With 4 Cycles of Immediate Chemotherapy Versus Androgen Blockade with Delayed Chemotherapy" Study Closed and Terminated
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0012
|
SWOG
|
A Comparative Randomized Study of Standard Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel as Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0023
|
SWOG
|
A Phase III Trial of Cisplatin/Etoposide/ Radiotherapy with Consolidation Docetaxel Followed by Maintenance Therapy with ZD1839 or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0106
|
SWOG
|
A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg) during Induction Therapy Versus Standard Induction with Daunomycin and Cytosine Arabinoside Followed by Consolidation and Subsequent Randomization to Post-Consolidation Therapy with Gemtuzumab Ozogamicin (Mylotarg) or No Additional Therapy for Patients Under Age 61 with Previously Untreated De Novo Acute Myeloid Leukemia (AML)
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0124
|
SWOG
|
Randomized Phase III Trial of Cisplatin (NSC-119875) and Irinotecan (NCSC-616348) Versus Cisplatin and Etoposide (NSC-141540) in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC)
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0200
|
SWOG
|
A Phase III Randomized Study of Pegylated Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients with Recurrent Epithelial Ovarian or Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0205
|
SWOG
|
A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine as First-Line Therapy of Patients with Advanced Pancreas Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S0221
|
SWOG
|
Phase III Trial of Continuous Schedule AC+G Vs. Q2 Week Schedule AC; Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S0226
|
SWOG
|
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women with Metastatic Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|